Netherlands: COVID Vaccine Age Recommendation Raised to 70+ by Health Council

The Netherlands is adjusting its COVID-19 vaccination strategy, shifting the recommended age for booster shots from 60 years and older to 70 years and older. This change, announced by the Health Council (Gezondheidsraad), reflects evolving data on the severity of COVID-19 illness and hospitalization rates across different age groups. The move aims to focus vaccination efforts on those most vulnerable to serious complications from the virus, while acknowledging the broader population immunity built through prior vaccinations and infections.

This adjustment in policy comes as the coronavirus continues to circulate, albeit with less severity than in earlier phases of the pandemic. While the virus is still present year-round and continues to mutate, leading to periodic surges, the risk of severe illness and hospitalization is now significantly lower, particularly among younger and healthier individuals. The Health Council’s recommendation is based on the observation that hospitalizations are now rare in healthy individuals under the age of 70. This shift prioritizes protection for those at highest risk, aligning with current scientific understanding and resource allocation.

Shifting Focus to High-Risk Groups

The updated guidance from the Health Council specifies that individuals aged 70 and older will be prioritized for the autumn 2026 vaccination round. Those aged 50 to 69 with underlying medical conditions that increase their risk of severe COVID-19 – the same conditions that qualify individuals for annual flu shots – will also be eligible. This includes individuals with serious immune deficiencies, as well as healthcare workers in direct contact with vulnerable patients. Adults and children within medically high-risk groups, as defined by their physicians, will continue to have access to vaccinations throughout the year, with a referral from their doctor.

Notably, the Health Council has determined that individuals aged 18 to 49 who routinely receive the annual flu vaccine will no longer be offered a COVID-19 booster. This decision, initially implemented in 2025, remains in effect for 2026, reflecting the lower risk of severe outcomes in this age group. Similarly, the Health Council no longer recommends routine COVID-19 vaccination for pregnant individuals, citing the increased population immunity and the less severe nature of the Omicron variant. The National Institute for Public Health and the Environment (RIVM) confirms this updated guidance.

Accessing Vaccination with a Referral

For individuals who require a COVID-19 vaccination outside of the standard autumn round – for example, those with specific medical conditions requiring additional protection – a referral from a general practitioner is necessary. The RIVM states that individuals with a valid referral can schedule an appointment at the Municipal Health Service (GGD) throughout the year by calling 0800-7070. This provision extends to individuals temporarily residing in the Netherlands without a Dutch passport, provided they have been in the country for longer than one month.

The ongoing availability of vaccinations with a referral underscores the commitment to providing targeted protection to those who need it most. This approach allows for a flexible response to individual health needs while optimizing the use of resources. The GGD remains a key point of access for vaccinations, ensuring equitable distribution and accessibility across the country.

The Evolving Nature of COVID-19

The Health Council’s revised recommendations acknowledge the evolving nature of the coronavirus. The virus continues to change, developing new variants that can partially evade existing immunity. In other words that while population immunity provides a significant level of protection, periodic vaccination remains important for maintaining robust defense against severe illness, particularly for vulnerable populations. The RIVM emphasizes that the virus is likely to remain present year-round, with potential for recurring waves of infection.

The decision to raise the age threshold for routine vaccination reflects a broader shift in public health strategy, moving from a mass vaccination approach to a more targeted approach focused on protecting those most at risk. This strategy is informed by ongoing monitoring of infection rates, hospitalization data, and the characteristics of circulating variants. The Health Council will continue to review and update its recommendations as the situation evolves.

What This Means for Different Groups

For individuals aged 70 and older, the autumn 2026 vaccination round will be crucial for maintaining protection against severe COVID-19. Those with underlying medical conditions between the ages of 50 and 69 should discuss vaccination with their physician to determine if a booster is recommended. Individuals in medically high-risk groups, regardless of age, should continue to follow the guidance of their healthcare provider and obtain a referral for vaccination as needed.

Those aged 60-69 who are otherwise healthy will no longer be automatically invited for a booster, but they are encouraged to discuss their individual risk factors with their doctor. The Health Council’s decision is based on the understanding that the risk of severe illness is significantly lower in this group, and the benefits of vaccination may be outweighed by potential risks. The focus remains on protecting the most vulnerable members of society.

The RIVM notes that the coronavirus is likely to behave similarly to the influenza virus, requiring annual monitoring and potential adjustments to vaccination strategies. The ongoing surveillance of the virus and its variants will be essential for informing future recommendations and ensuring effective public health responses. The Dutch government’s website provides further information on the coronavirus vaccination program.

Key Takeaways

• The recommended age for routine COVID-19 vaccination in the Netherlands has been raised from 60 to 70 years ancient.
• Individuals aged 50-69 with underlying medical conditions remain eligible for vaccination.
• Vaccination remains available year-round for those in medically high-risk groups with a referral from their doctor.
• The Health Council emphasizes the importance of targeted vaccination to protect the most vulnerable populations.

The next key update regarding the COVID-19 vaccination program is expected in the spring of 2027, when the Health Council will review the latest data and make recommendations for the autumn 2027 vaccination round. Readers are encouraged to share their thoughts and experiences in the comments below and to share this article with their networks to promote informed decision-making.